Equivalent Binding Of Sera From Omicron And Delta Period To Future Omicron Subvariants.
Biswas, D.; Mahalingam, G.; Subaschandrabose, R. K.; Priya, S.; Ramachandran, R.; Suresh, S.; Mathivanan, T. V.; Balu, N. V.; Selvaraj, K.; Nellickal, A. J.; Christudoss, P.; Samuel, P.; Devi KT, R.; Marepally, S.; Moorthy, M.
Show abstract
Throughout the COVID-19 pandemic, virus evolution and large-scale vaccination programs have caused multiple exposures to SARS CoV-2 spike protein, resulting in complex antibody profiles. Binding of sera to spike protein of future variants in the context of heterogeneous exposure, has not been studied. We tested archival sera (delta and omicron period) stratified by anti-spike levels for reactivity to omicron subvariant (BA.1, BA.2, BA.2.12.1, BA.2.75, BA.4/5 and BF.7) spike. Antibody reactivity to wild-type (CLIA) and subvariants (ELISA) spike were similar between periods (p>0.05). Both High S group and Low S group of delta and omicron periods were closely related to future subvariants by Antigenic Cartography. Anti-spike antibodies to wild type (S1/S2 and Trimeric S) clustered with subvariant-binding antibodies. Low S group interspersed between High S group on hierarchical clustering. Hybrid immunity caused by cumulative virus exposure in delta or omicron periods caused equivalent binding to future variants. Low S antibody group demonstrating similar binding is a prominent finding.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients 93%
- A highly sensitive and specific SARS-CoV-2 spike- and nucleoprotein-based fluorescent multiplex immunoassay (FMIA) to measure IgG, IgA and IgM class antibodies 93%
- Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants 93%
Similar papers in this journal
- Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods 95%
- Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients 95%
- Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India 94%
Similar papers in this journal
- Mucosal antibody response to SARS-CoV-2 in paediatric and adult patients: a longitudinal study 93%
- Polymorphism and selection pressure of SARS-CoV-2 vaccine and diagnostic antigens: implications for immune evasion and serologic diagnostic performance 93%
- Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: moving toward a universal vaccine for the "confined virus"? 92%
Similar papers in this journal
- Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform 95%
- Prevalence of anti-SARS-CoV-2 immunity in Kazakhstan before the launch of COVID-19 vaccination 94%
- A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects 94%
Similar papers in this journal
- Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease 95%
- Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics 94%
- Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.